Hormonal treatment for urinary incontinence is typically delivered as which form?

Hormonal treatment for urinary incontinence is typically delivered as which form?

• A. Urge Incontinence
• B. Anticholinergics
• C. Topical Estrogen
• D. Indwelling Catheters

Answer: (C)

Hormonal treatment for urinary incontinence is typically delivered as topical estrogen because the decline in estrogen after menopause leads to thinning and drying of the vaginal and urethral tissues. When estrogen is applied locally to these areas, it restores tissue thickness, elasticity, and blood flow, which helps improve the support and function around the urethra and reduces leakage associated with atrophic changes. The key advantage is that this approach works mainly where it’s needed and carries minimal systemic absorption, lowering overall hormonal risks compared with systemic estrogen therapy. Other options shown—anticholinergics target bladder contractions for urge symptoms, while indwelling catheters are a mechanical management method—not hormonal treatments.

Hormonal treatment for urinary incontinence is typically delivered as topical estrogen because the decline in estrogen after menopause leads to thinning and drying of the vaginal and urethral tissues. When estrogen is applied locally to these areas, it restores tissue thickness, elasticity, and blood flow, which helps improve the support and function around the urethra and reduces leakage associated with atrophic changes. The key advantage is that this approach works mainly where it’s needed and carries minimal systemic absorption, lowering overall hormonal risks compared with systemic estrogen therapy. Other options shown—anticholinergics target bladder contractions for urge symptoms, while indwelling catheters are a mechanical management method—not hormonal treatments.